Global Blood Therapeutics, Inc.
DOSING REGIMENS FOR 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALD- EHYDE
Last updated:
Abstract:
Provided herein are methods for treating sickle cell disease, comprising administering to a subject 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)-methoxy)benzal- dehyde (Compound 1), or a polymorph thereof, in certain dosing regimens.
Status:
Application
Type:
Utility
Filling date:
20 May 2021
Issue date:
2 Sep 2021